MUCOLYTIC THERAPY FOR LOWER RESPIRATORY TRACT DISEASES IN CHILDREN
The clinical and immunological efficacies of carbocysteine lysine salt (CLS) were evaluated in 2-to-17-year-old children with acute respiratory infections of the lower respiratory tract and exacerbations of chronic bronchopulmonary diseases. CLS was shown to be more effective than the conventional herbal expectorants and acetylcysteine